Diagnosis and treatment of acute myocardial infarction in tertiary and secondary care hospitals in Estonia

Scandinavian Journal of Public Health

Volumn 34, Issue 3, 2006, Pages 327-331

  Ainla, Tiia ^a   Teesalu, Rein ^a   Elmet, Märt ^a   Marandi, Toomas ^b   Lver, Anita ^b   Peeba, Margus ^b   Voitk, Jüri ^b   Baburin, Aleksei ^c  

^a UNIVERSITY OF TARTU   (Estonia)

^b North Estonia Regional Hospital   (Estonia)

^c NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

Author keywords

acute myocardial infarction; diagnosis; hospital type; treatment

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESTONIA; FACTUAL DATABASE; FEMALE; FIBRINOLYTIC THERAPY; FREQUENCY ANALYSIS; HEALTH INSURANCE; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOM SAMPLE; STANDARDIZATION; TERTIARY HEALTH CARE; VALIDATION STUDY;

ADULT; AGED; CLINICAL COMPETENCE; ESTONIA; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES;

EID: 33744921901     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1080/14034940500242019     Document Type: Article

References (23)

1. Ministry of Social Affairs of Estonia. Social sector in figures 2002. Tallinn: 2002.
2. Sans S., Kesteloot H., Kromhaut D. The burden of cardiovascular diseases mortality in Europe. Eur Heart J 1997;18:1231-1248.
3. Capewell S., Morrison C.E., McMurray J.J. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999; 81:380-6.
4. Heidenreich P.A., McClellan M. Trends in treatment and outcomes for acute myocardial infarction: 1975—1995. Am J Med 2001;110:165-174.
5. Leinsalu M. Time trends in cause-specific mortality in Estonia from 1965 to 1989. Int J Epidemiol 1995;24: 106-113.
6. Fox K.A., Goodman S.G., Klein W., Brieger D., Steg P.G., Dabbous O., Avezum A. Management of acute coronary syndromes: Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23:1177-1189.
7. Hasdai D., Behar S., Wallentin L., Danchin N., Gitt A.K., Boersma E., et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin: The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey). Eur Heart J 2002; 23:1190-1201.
8. Gottwik M., Zahn R., Schiele R., Schneider S., Gitt A.K., Fraunberger L., et al. Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology. Eur Heart J 2001;22:1784-1801.
9. Jollis J.G., DeLong E.R., Peterson E.D., Muhlbaier L.H., Fortin D.F., Califf R.M., Mark D.B. Outcome of acute myocardial infarction according to the speciality of the admitting physician. N Engl J Med 1996;335:1880-7.
10. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined — a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-1513.
11. Task Force of the European Society of Cardiology. Acute myocardial infarction: Pre-hospital and in-hospital management. Eur Heart J 1996;17:43-63.
12. Committee on Management of Acute Myocardial Infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 1999;34:890-911.
13. Task Force of European Society of Cardiology. Bertrand M.E., Simoons M.L., Fox K., Wallentin L.C., Hamm C.W., McFadden E., et al. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation. Eur Heart J 2000;21: 1406-1432.
14. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th revision. Geneva: WHO, 1992.
15. Acute Coronary Syndromes Writing Committee. A report of the American College of Cardiology Task Force on Clinical Data Standards. American College of Cardiology key elements and data definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. J Am Coll Cardiol 2001;38:2114-2130.
16. Stata user's guide, College Station, TX: Stata Press, 1997.
17. Abramson J.H., Gahlinger P.M. Computer Programs for Epidemiologic Analyses: PEPI v. 4.0 [available at: http://www.sagebrushpress.com/pepibook.html;www.brixtonhealth.com].
18. Hasdai D., Behar S., Boyko V., Danchin N., Bassand J.P., Battler A. Cardiac biomarkers and acute coronary syndromes: The Euro Heart Survey of Acute Coronary Syndromes Experience. Eur Heart J 2003;24:1189-1194.
19. Van Berkel TFM, Boersma H., De Barque D., Deckers J.W., Wood D., on behalf of the EUROASPIRE Study Group. Registration and management of smoking behavior in patients with coronary heart disease. Eur Heart J 1999;20:1630-7.
20. Harnick D.J., Cohen J.L., Schechter C.B., Fuster V., Smith D.A. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease. Am J Cardiol 1998;81:1416-1420.
21. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322.
22. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986;2:57-66.
23. Latini R., Maggioni A.P., Flather M., Sleight P., Tognoni G. ACE inhibitor use in patients with myocardial infarction: summary of evidence from clinical trials. Circulation 1995;92:3132-7.